Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung Cancer
Clinical trial NCT02031601 · UNKNOWN
Trial details
- NCT number
- NCT02031601
- Sponsor
- Qilu Hospital of Shandong University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2016-12-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.